Friday, November 2, 2012

FDA expands Xarelto use to DVT, PE

›
The FDA today voted to expand the approved use of rivaroxaban (Xarelto, Janssen Pharmaceuticals) to include the treatment of deep vein thro...
10 comments:
Tuesday, September 4, 2012

Olanzapine for Break through nausea and vomiting

›
Anti-psychotic medication helps control breakthrough CINV Thanks HemOnc Today, July 10, 2012 CHICAGO — The anti-psychotic medicati...
2 comments:
Friday, August 31, 2012

FDA approves enzalutami​de to treat patients with metastatic castration​-resistant prostate cancer who previously received docetaxel

›
On August 31, 2012, the U. S. Food and Drug Administration approved enzalutamide (XTANDI® Capsules, Medivation, Inc. and Astellas Pharma US,...
1 comment:
Monday, August 6, 2012

New Treatment for Colon Cancer : ziv-aflibercept

›
On August 3, 2012, the U. S. Food and Drug Administration approved ziv-aflibercept injection (ZALTRAP®, Sanofi U.S., Inc.) for use in comb...
1 comment:
Friday, April 27, 2012

FDA Approves GSK Cancer Drug Votrient For Soft-Tissue Sarcoma

›
WASHINGTON (Dow Jones)--The Food and Drug Administration on Thursday approved GlaxoSmithKline PLC's (GSK, GSK.LN) cancer drug Votrient...
Monday, March 19, 2012

AAP now recommends HPV (Human Papilloma Virus) vaccine for boys and girls

›
The American Academy of Pediatrics Committee on Infectious Diseases issued an updated policy statement on human papillomavirus vaccination t...
Sunday, March 11, 2012

Chemotherapy for Metastatic Colon Cancer

›
CHEMOTHERAPY FOR UNRESECTABLE COLORECTAL CANCER: As noted above, surgery is the only way to cure metastatic colorectal cancer. In most cas...
1 comment: